Julie O'neill - Net Worth and Insider Trading
Julie O'neill Net Worth
The estimated net worth of Julie O'neill is at least $8 Million dollars as of 2024-11-13. Julie O'neill is the EVP. Global Operations of Alexion Pharmaceuticals Inc and owns about 42,787 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $8 Million. Details can be seen in Julie O'neill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julie O'neill has not made any transactions after 2018-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Julie O'neill
Julie O'neill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julie O'neill owns 2 companies in total, including DBV Technologies SA (DBVT) , and HOOKIPA Pharma Inc (HOOK) .
Click here to see the complete history of Julie O'neill’s form 4 insider trades.
Insider Ownership Summary of Julie O'neill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DBVT | DBV Technologies SA | 2021-01-01 | director |
| HOOK | HOOKIPA Pharma Inc | 2019-04-17 | director |
Julie O'neill Latest Holdings Summary
Julie O'neill currently owns a total of 1 stock. Julie O'neill owns 42,787 shares of Alexion Pharmaceuticals Inc (ALXN) as of February 28, 2018, with a value of $8 Million.
Latest Holdings of Julie O'neill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2018-02-28 | 42,787 | 182.50 | 7,808,628 |
Holding Weightings of Julie O'neill
Julie O'neill Form 4 Trading Tracker
According to the SEC Form 4 filings, Julie O'neill has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 1,625 shares on February 28, 2018, which brought Julie O'neill around $194,724.
Insider Trading History of Julie O'neill
- 1
Julie O'neill Trading Performance
Julie O'neill Ownership Network
Ownership Network List of Julie O'neill
Ownership Network Relation of Julie O'neill
Julie O'neill Owned Company Details
What does DBV Technologies SA do?
Who are the key executives at DBV Technologies SA?
Julie O'neill is the director of DBV Technologies SA. Other key executives at DBV Technologies SA include Chief Medical Officer Pharis Mohideen , director & Chief Executive Officer Daniel Tasse , and Chief Financial Officer Virginie Boucinha .
DBV Technologies SA (DBVT) Insider Trades Summary
Over the past 18 months, Julie O'neill made no insider transaction in DBV Technologies SA (DBVT). Other recent insider transactions involving DBV Technologies SA (DBVT) include a net sale of 7,333 shares made by Pharis Mohideen , a net purchase of 17,094 shares made by Daniel Tasse , and a net purchase of 15,000 shares made by Daniel B Soland .
In summary, during the past 3 months, insiders sold 0 shares of DBV Technologies SA (DBVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,559 shares of DBV Technologies SA (DBVT) were sold and 22,960 shares were bought by its insiders, resulting in a net purchase of 18,401 shares.
DBV Technologies SA (DBVT)'s detailed insider trading history can be found in Insider Trading Tracker table.
DBV Technologies SA Insider Transactions
Julie O'neill Mailing Address
Above is the net worth, insider trading, and ownership report for Julie O'neill. You might contact Julie O'neill via mailing address: C/o Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
